BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38700854)

  • 1. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
    Hung A; Wilson L; Smith VA; Pavon JM; Sloan CE; Hastings SN; Farley J; Maciejewski ML
    JAMA Health Forum; 2024 May; 5(5):e240807. PubMed ID: 38700854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
    Miller DE; Roane TE; Salo JA; Hardin HC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic disparities related to the Medicare Part D Medication Therapy Management Program.
    Allen A; Hung A
    J Manag Care Spec Pharm; 2024 Jun; 30(6):609-616. PubMed ID: 38824629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
    Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
    Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the Comprehensive Care for Joint Replacement Model With Disparities in the Use of Total Hip and Total Knee Replacement.
    Thirukumaran CP; Kim Y; Cai X; Ricciardi BF; Li Y; Fiscella KA; Mesfin A; Glance LG
    JAMA Netw Open; 2021 May; 4(5):e2111858. PubMed ID: 34047790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
    Wang J; Brown LM; Hong SH
    J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Socioeconomic and Geographical Characteristics of Beneficiaries Receiving a Comprehensive Medication Review.
    Chou J; Pellegrin K; Cooke CE; Zarowitz B; Hanlon A; Lozano A; Brandt NJ
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1276-1281. PubMed ID: 32996388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer's Disease: an observational analysis.
    Browning JA; Tsang CCS; Dong X; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Liu C; Wang J
    BMC Health Serv Res; 2022 Feb; 22(1):159. PubMed ID: 35130899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the Comprehensive Medication Review Completion Rate for Medicare Part D Plans: What Do the Stars Tell Us?
    Cooke CE; Olshanskaya S; Lee M; Brandt NJ
    Sr Care Pharm; 2022 Aug; 37(8):357-365. PubMed ID: 35879850
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic Variation and Disparities in Total Joint Replacement Use for Medicare Beneficiaries: 2009 to 2017.
    Thirukumaran CP; Cai X; Glance LG; Kim Y; Ricciardi BF; Fiscella KA; Li Y
    J Bone Joint Surg Am; 2020 Dec; 102(24):2120-2128. PubMed ID: 33079898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC; Wan JY; Chisholm-Burns MA; Li M; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Res Social Adm Pharm; 2021 Aug; 17(8):1469-1477. PubMed ID: 33272859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities in Health Care Use and Access Associated With Loss of Medicaid Supplemental Insurance Eligibility Above the Federal Poverty Level.
    Roberts ET; Kwon Y; Hames AG; McWilliams JM; Ayanian JZ; Tipirneni R
    JAMA Intern Med; 2023 Jun; 183(6):534-543. PubMed ID: 37036727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
    O'Shea TE; Zarowitz BJ; Erwin WG
    J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do comprehensive medication review completion rates predict medication use and management quality?
    Wang Y; Farley JF; Ferreri SP; Renfro CP
    Res Social Adm Pharm; 2019 Apr; 15(4):417-424. PubMed ID: 30917893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas.
    Nathan AS; Yang L; Yang N; Eberly LA; Khatana SAM; Dayoub EJ; Vemulapalli S; Julien H; Cohen DJ; Nallamothu BK; Baron SJ; Desai ND; Szeto WY; Herrmann HC; Groeneveld PW; Giri J; Fanaroff AC
    JAMA Cardiol; 2022 Feb; 7(2):150-157. PubMed ID: 34787635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and ethnic disparities in benefits eligibility and spending among adults on the autism spectrum: A cohort study using the Medicare Medicaid Linked Enrollees Analytic Data Source.
    Benevides TW; Carretta HJ; Rust G; Shea L
    PLoS One; 2021; 16(5):e0251353. PubMed ID: 34032811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.
    Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC
    Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.